GA
Giasuddin Ansari
About Giasuddin Ansari
Giasuddin Ansari has 5 years in corporate governance. Holds Director role. Currently with 3 companies, including Medpray Healthcare Private Limited and Tribe Commerce Private Limited. Formerly with 1 company, such as Artificial Wit Technologies Private Limited. Engaged in Healthcare, General Business and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Medpray Healthcare Private Limited
U62011UP2025PTC225790
|
Director | 09 Jun 2025 | 2025 | Active |
|
Tribe Commerce Private Limited
U62090UP2025PTC220234
|
Director | 02 Apr 2025 | 2025 | Active |
|
Bitlyze Technologies Private Limited
U72900UP2022PTC175714
|
Director | 27 Jun 2024 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Artificial Wit Technologies Private Limited
U72900UP2020PTC132417
|
Director | 10 Aug 2020 | 2020 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Giasuddin Ansari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Giasuddin Ansari
Giasuddin Ansari has 5 years in corporate governance. Holds Director role. Currently with 3 companies, including Medpray Healthcare Private Limited and Tribe Commerce Private Limited. Formerly with 1 company, such as Artificial Wit Technologies Private Limited. Engaged in Healthcare, General Business and more. Contributes to corporate operations.
Giasuddin Ansari is associated with 3 companies as Director.
Giasuddin Ansari has expertise in Healthcare, General Business and other sectors.
Giasuddin Ansari has 5 years in corporate governance.